Company-wide revenue
Reported revenue in 2021 ¥5.64B Reported revenue in 2025 ¥9.77B
- growth amount
- +¥4.13B
- growth annualized
- +14.7%
- growth total
- +73.2%
Japanese company profile · 7317
Matsuya R&D Co.,Ltd
In its FY2025 public filing, Matsuya R&D Co.,Ltd reports Medical healthcare, Safety system. The page shows business-level revenue and profit where the source disclosures support comparison.
Original Japanese company name: 株式会社松屋アールアンドディ
English company name recorded in Japan's EDINET filer data. English company name source
Reported company-wide figures
What does this company do?
What does this company do?
Matsuya R&D Co.,Ltd's largest reported business by revenue in FY2025 was Medical healthcare.
The business with the highest reported segment profit in FY2025 was Medical healthcare.
FY2025 · fiscal year ended March 2026 View original filing ↗ The source document may be in Japanese.
Business structure
How does it make money?
| Business | Sales | Revenue share | Operating profit |
|---|---|---|---|
| Medical healthcare | ¥6.81B ↗ | 69.7% | ¥2.12B ↗ |
| Safety system | ¥2.86B ↗ | 29.3% | ¥397.32M ↗ |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended March 2026. Revenue and profit are shown only where the filing and data support a comparison.
Original Japanese label
- Medical healthcare
- メディカルヘルスケア
- Safety system
- セイフティシステム
- Business label unavailable in English
- 縫製自動機
- Business label unavailable in English
- 縫製品
- Sales
- 売上高
- Operating profit
- 営業利益
Original Japanese label
- Medical healthcare
- メディカルヘルスケア
- Safety system
- セイフティシステム
- Business label unavailable in English
- 縫製自動機
- Business label unavailable in English
- 縫製品
- Sales
- 売上高
- Operating profit
- 営業利益
What is growing?
What is growing?
Business revenue growth
Medical healthcare
Reported revenue in 2022 ¥5.13B Reported revenue in 2025 ¥6.81B
- growth amount
- +¥1.67B
- growth annualized
- +9.9%
- growth total
- +32.6%
View original filing
Safety system
Reported profit margin in 2022 -17.4%
Reported profit margin in 2025 +13.9%
- growth margin points
- +31.3
View original filing
Medical healthcare
Reported profit margin in 2022 +23.8%
Reported profit margin in 2025 +31.2%
- growth margin points
- +7.4
View original filing
This describes a reported period; it is not a forecast.
What has changed?
What has changed?
Not disclosed or not safely comparable in the available filings.
Source
Public filing
FY2025 · fiscal year ended March 2026
The source document may be in Japanese.
Filing ID: S100YI6P
View original filing ↗Ask about this company
Ask about this company
The source document may be in Japanese.